AU6697174A - Hepatitis b virus detection bythe reversed passive hemagglutination method - Google Patents

Hepatitis b virus detection bythe reversed passive hemagglutination method

Info

Publication number
AU6697174A
AU6697174A AU66971/74A AU6697174A AU6697174A AU 6697174 A AU6697174 A AU 6697174A AU 66971/74 A AU66971/74 A AU 66971/74A AU 6697174 A AU6697174 A AU 6697174A AU 6697174 A AU6697174 A AU 6697174A
Authority
AU
Australia
Prior art keywords
bythe
hepatitis
virus detection
passive hemagglutination
hemagglutination method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU66971/74A
Other versions
AU487056B2 (en
Inventor
Atsunobu Hirata Arthur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of AU487056B2 publication Critical patent/AU487056B2/en
Publication of AU6697174A publication Critical patent/AU6697174A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU66971/74A 1973-04-23 1974-03-21 Hepatitis b virus detection bythe reversed passive hemagglutination method Expired AU487056B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35386073A 1973-04-23 1973-04-23
USUS353,860 1973-04-23

Publications (2)

Publication Number Publication Date
AU487056B2 AU487056B2 (en) 1975-09-25
AU6697174A true AU6697174A (en) 1975-09-25

Family

ID=

Also Published As

Publication number Publication date
FR2226662B1 (en) 1979-09-28
JPS5012227A (en) 1975-02-07
FR2226662A1 (en) 1974-11-15
ZA741802B (en) 1975-02-26
GB1442546A (en) 1976-07-14
DE2419230A1 (en) 1974-11-14

Similar Documents

Publication Publication Date Title
SE382496B (en) SET AND FACILITY FOR VERMEAT RECOVERY.
NL161904C (en) THEFT DETECTION SYSTEM.
IT1009635B (en) POLYMERIZATION PROCESS
NL7611674A (en) POLYMERIZATION PROCESS.
NL7409225A (en) PULSE DETECTION SYSTEM.
ES205552Y (en) PERFECTED SPANOLET LOCK.
BE810697A (en) VIRUS INACTIVATION
IT1022688B (en) POLYMERIZATION PROCESS
NL7514322A (en) KANAMYCINE DERIVATIVES AND PROCESS FOR PREPARING THEM.
BG25999A3 (en) ETHYLENE POLYMERIZATION METHOD
NL189855C (en) OXYCHLORATION PROCESS.
NO140180C (en) VACUUM VOMITER.
AR200816A1 (en) PACKAGING METHOD
ZA741802B (en) Hepatitis b virus detection by the reversed passive hemagglutination method
NL7409243A (en) COPOLYMERIZATION METHOD.
AU487056B2 (en) Hepatitis b virus detection bythe reversed passive hemagglutination method
ATA849974A (en) VACUUM FRESHING PROCESS
NL7502208A (en) POLYMERIZATION METHOD.
AT337328B (en) LOW-FOAM DETERGENT, DETERGENT AND DETERGENT
SE7505015L (en) PROCEDURE FOR CONCENTRATING LATEXAR.
NL7310636A (en) MULTI-STAGE DISTILLER.
SU493127A1 (en) Virus inhibitor
ES208914Y (en) PERFECTED SEALING PACKAGING.
CA917073A (en) Vaccine against viral hepatitis and process
ES199495Y (en) VACUUM MULTIPLIER GROUP.